1/9
#AIDICU trial results on haloperidol vs. placebo for the treatment of delirium in ICU patients @NEJM
Amazing work in 16 ICUs 🇩🇰🇫🇮🏴🇮🇹
Funded by
@Innofond
@regionsjaelland@regionerne
https://t.co/bh19n2V53A
#COVID19 cardiovascular impact in critically ill
➡️pathophysiology behind increased long term risk?
➡️trajectory of US findings?
➡️influence of vaccines/immunomodulatory drugs?
➡️role for prophylaxis?
📖https://t.co/DjNIjAcxY5
Refers to ECHO-COVID study
📖https://t.co/E1XUXGEunA
One of the most outstanding questions in critical care is whether patients benefit from IV fluid resuscitation in septic shock.
A thread...
(image shutterstock)
1/16
The 532nd Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature for the week February 14th to 20th, is now out
https://t.co/khd9HZXTub
CCR is supported by @MyIntensiveCare
Only 100 to go in #CLASSICtrial. Restricted vs standard IV fluids in adults w. septic shock. Outstanding work from 31 ICUs 🇩🇰🇨🇭🇸🇪🇳🇴🇨🇿🇮🇹🇧🇪🇬🇧
@AndersPerner @TineMeyhoff @MortenHylander @pbhjortrup
@CritCareReviews Superb planning, execution, and presentation of RADAR2 @jon_silversides and group! Very interesting data - looking much forward to reading the full report.
The unedited videos of the first 2 days of #eCCR21 are now available on the (temporary...) website.
I'll get the edited versions up as quick as I can
https://t.co/zgMQNMrTdc
Just 9 weeks to eCCR21. We start to release the programme this week. Just the 5 major trial results to be hosted, 11 of the best critical care trials of 2020 to be presented by their chief investigators, plus a little more...
All freely live streamed.
#eCCR21
Er du vores næste ph.d. studerende?
Ph.d. studerende søges til Centre of Anaesthesiological Reserach, Anæstesiologisk Afdeling, SUH, Køge via https://t.co/XzxhkzdQ7E https://t.co/QtKWOQ5gfU
#ICU pts receive vast amounts of IV fluids: choosing right solution/volume to avoid harm challenging. Design/conduction of trials complex, lot of unanswered questions: debates not likely to end soon but each high-quality trial is small step toward solution https://t.co/DvkuiH5xu4
Good news in the midst of the pandemic.
The CLASSIC trial is halfway!
Thanks a million to clinical staff, relatives and patients! Trial results will improve outcomes of septic shock.
@AndersPerner @TineMeyhoff @pbhjortrup @MortenHylander @Majkja
Finally a good study on High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study accepted by @yourICM by @juliehelms available at https://t.co/iYdn6Ya2qI as preproof
500 patients randomized in the AID-ICU trial and thereby halfway - improving outcomes for #icudelirium! Thanks to all our AID-investigators.
@MusaeusPoulsen
@AndersPerner
@BodilSRasmussen
The Surviving Sepsis Campaign guidelines for severe #COVID19 in ICU under review at @yourICM will be available probably before the weekend on the @ESICM website as pre-proof document.
Now >700 patients included in #classictrial - we're still recruiting and we're almost halfway!
Improving outcomes for #septicshock , including that caused by critically ill patients with #SARSCOV2
@AndersPerner @TineMeyhoff @Majkja @MortenHylander @pbhjortrup